WINTON GROUP Ltd Buys 226,979 Shares of Core Scientific, Inc. $CORZ

WINTON GROUP Ltd lifted its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 1,304.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 244,379 shares of the company’s stock after purchasing an additional 226,979 shares during the period. WINTON GROUP Ltd’s holdings in Core Scientific were worth $3,558,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CORZ. Allworth Financial LP raised its stake in shares of Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after purchasing an additional 950 shares in the last quarter. Larson Financial Group LLC raised its stake in shares of Core Scientific by 936.7% during the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares in the last quarter. Osaic Holdings Inc. raised its stake in shares of Core Scientific by 112.1% during the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after purchasing an additional 1,066 shares in the last quarter. Danske Bank A S bought a new stake in shares of Core Scientific during the 4th quarter worth approximately $36,000. Finally, State of Wyoming bought a new stake in shares of Core Scientific during the 4th quarter worth approximately $66,000.

Core Scientific Stock Performance

CORZ stock opened at $25.85 on Monday. The firm has a market capitalization of $8.22 billion, a PE ratio of -22.68 and a beta of 5.49. Core Scientific, Inc. has a 1-year low of $10.93 and a 1-year high of $30.46. The business’s 50 day simple moving average is $21.58 and its 200 day simple moving average is $18.43.

Core Scientific (NASDAQ:CORZ) last posted its earnings results on Wednesday, May 6th. The company reported ($1.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($1.04). The company had revenue of $115.24 million during the quarter, compared to analyst estimates of $117.04 million. The company’s revenue was up 44.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.25 earnings per share. As a group, sell-side analysts predict that Core Scientific, Inc. will post 0.08 EPS for the current fiscal year.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $26.25, for a total value of $262,500.00. Following the transaction, the insider directly owned 2,088,895 shares of the company’s stock, valued at $54,833,493.75. This represents a 0.48% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last quarter, insiders sold 60,000 shares of company stock worth $1,195,900. 1.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

CORZ has been the topic of a number of analyst reports. BTIG Research upped their price objective on Core Scientific from $23.00 to $33.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. HC Wainwright reiterated a “buy” rating and set a $25.00 price objective on shares of Core Scientific in a research note on Tuesday, March 3rd. B. Riley Financial upped their price objective on Core Scientific from $30.00 to $33.00 and gave the stock a “buy” rating in a research note on Wednesday, May 27th. Canaccord Genuity Group set a $30.00 target price on Core Scientific in a report on Friday, May 8th. Finally, Cantor Fitzgerald boosted their target price on Core Scientific from $25.00 to $29.00 and gave the stock an “overweight” rating in a report on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $28.83.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.